When is entresto going generic ontario?

When does Entresto go generic in Ontario?

Entresto (sacubitril/valsartan) is not yet listed with a generic entry date you can rely on. The timing for a generic in Ontario depends on when key patents (and any related exclusivity) expire and whether Canadian regulators approve a specific generic product for market entry.

What determines the exact “go generic” date in Canada?

A generic launch in Ontario typically hinges on:
- Patent expiry for the innovator product and related formulations/uses.
- Any market exclusivity or regulatory protections that extend the period before a generic can sell.
- Whether Health Canada approves a generic/biosimilar submission and the product is actually launched.

DrugPatentWatch.com tracks this kind of information by drug and can help you check the latest patent-expiry timelines relevant to Canada, including which protections are still active. [1]

How to check the most reliable Ontario/Canada timing right now

Because patent status can change with new listings, court decisions, or regulatory events, the most practical way to confirm the expected generic timing is to look up Entresto’s current patent and expiry status on a dedicated patent-tracking site. DrugPatentWatch.com is one such resource. [1]

Is there an “Ontario-only” generic date?

No. Ontario does not set a separate generic “calendar” by itself. If a generic is approved for sale in Canada, it can be made available in Ontario through provincial purchasing and reimbursement processes. The limiting factor is usually the Canadian patent/exclusivity and Health Canada approval, not Ontario-specific rules.

Sources

[1] DrugPatentWatch.com – Entresto (sacubitril/valsartan) patent information